Skip to content ↓

IS&T announces full support for Internet Explorer 9

Will deliver IE9 to machines subscribed to the MIT Windows Automatic Update Service (WAUS).
Internet Explorer 9 logo
Caption:
Internet Explorer 9 logo
Credits:
Image used with permission from MIcrosoft

Information Services & Technology (IS&T) now offers full support for Internet Explorer 9 (IE9) running on Vista and Windows 7. Starting June 29, IS&T will deliver IE9 to machines subscribed to the MIT Windows Automatic Update Service (WAUS).

In collaboration with departments, labs, and centers (DLCs), IS&T has been testing IE9 since its initial release by Microsoft and has worked on resolving compatibility issues with various internal and external sites. IS&T has found that
  • Upgrading to IE9 from IE8 and IE7 works as expected, preserving user settings, bookmarks, and MIT personal certificates.
  • IE9's new features and improvements in security and usability will change to some extent how users interact with the browser.
Certificates and IE9

To obtain a new MIT personal certificate, IE 9 users should run CertAid for Internet Explorer. CertAid for Internet Explorer is not needed for win.mit.edu domain users.

Getting help

For help with installing or using IE9, contact the IS&T Help Desk at 617-253-1101 or helpdesk@mit.edu. You can also submit a request online.

IS&T has published IE9 product information for MIT on its website.

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story